Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-29
SponsorUniversity of Barcelona

About this trial

Depression and anxiety are the most prevalent mental disorders among both the general population and young adults, and transdiagnostic treatments for these patients are mostly based on cognitive-behavioral therapy (CBT). Based on common (transdiagnostic) principles of treatment (e.g., emotional exposure), these approaches have proliferated and demonstrated their efficacy in comparison to disorder-specific treatments. Although there are a few transdiagnostic approaches for children and adolescents, it was not possible to not find anyone targeting young people. For this reason, the investigators proposed the Identity-Based Transdiagnostic Therapy (IBTT) as a new treatment modality ideally created to address the challenge of improving the outcomes of psychotherapy for young adults with anxiety and/or depression. The IBTT is a psychological treatment for emotional disorders specifically designed for the youths in terms of their attitudes to treatment (attractiveness, engagement), and highly personalized to their construal of self and others. This project will allow testing the hypothesis that a novel brief psychotherapeutic intervention, IBTT, will be more efficacious in the treatment of the anxiety and/or depression of young adults than the well-established CBT-based Unified Protocol.

Eligibility criteria

Qualifiers

None

Disqualifiers

Participants with post-traumatic stress, bipolar and substance use disorders, psychotic symptoms, organic brain dysfunction, marked suicidal ideation and/or intellectual disability.

Participants receiving psychological treatment, unless it is suspended at the time of inclusion in the study itself in agreement with their therapist.

Participants for whom the use of virtual reality may pose a risk, even a minor risk (epilepsia, acute otorhinolaryngological processes or recent interventions, severe cardiovascular disease, unstable hypertension, and pregnancy).

Participants with substantial visual, hearing, and cognitive deficits.

Trial design

Treatments tested in this trial

  • Identity-Based Transdiagnostic Therapy (IBTT)
  • Unified Protocol

Treatment groups

138 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Barcelona

Lead sponsor

Badalona Serveis Assistencials

Collaborator

Nou Barris Mental Health Center

Collaborator